BeiGene, Ltd.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5.1% | -2.4% | +0.8% | +2.1% | +1.5% | -1.3% | +7.8% | +21.2% | +7.3% | +4.5% | +7.3% | |
| – | +3.7% | -7.0% | -1.8% | +1.9% | +2.0% | -2.4% | +10.6% | +31.4% | +10.0% | +5.9% | +9.3% | |
| – | +3.4% | -11.9% | -7.2% | +4.2% | -2.8% | -4.2% | +9.5% | +46.5% | +12.6% | +5.4% | +6.4% | |
| – | -0.1% | -11.9% | -7.2% | +4.2% | -2.8% | -4.2% | +9.5% | +46.5% | +12.6% | +5.4% | +6.4% | |
| – | +11.6% | +18.0% | +25.9% | +2.5% | +17.6% | +5.2% | +18.0% | +2.5% | -1.7% | +6.9% | +12.9% | |
| – | +31.3% | +7.5% | -0.9% | -2.6% | +14.7% | -0.1% | +1.7% | +5.7% | +14.4% | +12.1% | +7.5% | |
| – | +102.9% | -49.3% | -2.6% | +0.4% | +140.6% | -61.4% | +29.4% | -2.0% | -1.4% | -1.6% | -1.2% | |
| – | +28.7% | +1.7% | +1.7% | +2.1% | +8.1% | -9.5% | +7.9% | +38.6% | +9.3% | -0.9% | +5.5% | |
| – | +41.1% | +4.0% | +3.0% | +4.5% | +9.4% | -10.4% | +11.4% | +7.2% | -22.8% | -0.9% | +17.0% | |
| – | +101.9% | +19.2% | +2.7% | +1.4% | -1.4% | -10.0% | +5.6% | +0.4% | -83.8% | +1.5% | +55.7% | |
| – | -7.8% | +13.2% | -6.6% | -7.7% | +31.7% | -10.0% | -1.0% | +6.3% | +24.9% | -11.6% | +11.0% | |
| – | -2.4% | +0.7% | -6.9% | +1.2% | -11.2% | -3.8% | -8.8% | -4.5% | +589.2% | +0.1% | -8.3% | |
| – | -6.0% | -5.0% | +0.2% | +2.1% | -3.0% | +5.0% | +7.7% | +9.5% | +5.6% | +9.2% | +8.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.7% | +0.2% | +0.4% | +0.0% | +1.5% | +4.6% | +1.5% | +1.5% | -0.9% | +2.0% | +0.0% |
Data as of: August 14, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.